SupremeCourt

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Thursday, February 14, 2013

Dorling Kindersley v. Sanguine Technical Publishers

Posted on 10:42 AM by Unknown


A recent Delhi High Court order passed on 21 January, 2013  with respect to copyright licensing has come to our notice. An analysis of the judgement has been attempted in this blog post.

Facts:
In 2009, Pearson Education entered into an agreement with Sanguine Technical Publishers and its three partners, M.R.Kamalakar Pandit, Lal.M.Prasad and Dr.D.Ganesh Rao to co-brand engineering books. The agreement was for a period of 48 months and could be extended to 60 month.
In 2012, Pearson was informed by Mr. Prasad that Dr. Rao had resigned from the partnership firm and that he was no longer interested in having books which he authored or co-authored published under the agreement. Pearson contended that this was in breach of the agreement. Pearson requested Sanguine multiple times to disclose the details of the agreement they had with the authors. However, Sanguine refused to comply. It also came to the knowledge of Pearson that titles listed under their agreement with Sanguine was being published by another publishing house, namely, Reed Elsevier India Private Limited. Books already published by Pearson were also being published subsequently by Elsevier.

Therefore, Pearson filed a petition before the Delhi High Court with the prayer that Sanguine and its partners must be restrained from breaching their agreement with Pearson. They also prayed for the appointment of Local Commissioners( LC's) to conduct an inventory of the books in the agreement which were suspected to have been printed by other publishing houses including Elsevier, stored by Sanguine and its partners and to seize the same. The Court on 12th September, 2012 accordingly appointed three LC's to do the same.
 As a result, Elsevier filed this review petition before the Delhi High Court praying the Court to declare that the 12th September is not binding on them and asking for the desealing of the books seized by the LC's.

Contentions:
Elsevier has contended that they have not published the five titles seized by the LC"s as a servant, assignee, nominee, agent, representative or attorney of Sanguine or its partners. According to them, these titles were published pursuant to their agreement with Fillip Learning which had valid existing contracts with the authors of the titles. Their second contention is based on the fact that the LC's raided the premises of their distributors as well, resulting in great hardship to them in spite of the fact that they are not a party to the agreement with Pearson. Elsevier submits that if Pearson believed that their copyright was being infringed upon by it, then the right way forward for Pearson was to seek civil remedy for infringement of copyright.

Pearson responded by stating that Elsevier's petition suffered from the vice of mala fide as it was filed deliberately in collusion with Sanguine and its partners. They submitted that this application has been filed so that Sanguine and its partners do not have to reply to the main petition and consequently, do not have to divulge information vital to the previous and present petitions. Pearson also submitted that they had discovered that Sanguine and its partners were actively attempting to frustrate the 2009 agreement by entering into discussions with other publishing houses for the publication of titles, the exclusive rights of which are vested with Pearson.

 Moreover, Pearson submitted that the refusal to disclose the contracts between Sanguine, its partners, Elsevier and Fillip Learning indicated that Fillip Learning was owned by Sanguine or its partners. Furthermore, Pearson submits that the fact that their employee who played an active role in negotiating the terms of the 2009 agreement has now been employed  at Elsevier indicates that Sanguine and its partners have conspired to benefit Elsevier. Therefore, according to Pearson, unless there is full disclosure , Elsevier cannot be considered alien to the dispute at hand.

Ruling:
The Delhi High Court has held that Elsevier's application is not maintainable. The Court furnished the following reasons for dismissal of the petition: the review petition of Elsevier has already been rejected by the same court on 9/1/13 and no appeal to the 12th September order has been filed by  Sanguine or its partners,  Elsevier has furnished no documentary evidence to conclusively establish their contractual relationship with Fillip Learning nor have they given any details about Fillip Learning.

It has been established on facts that some of the titles under the 2009 agreement have been published by Elsevier. However, unless there is full disclosure it cannot be established whether Pearson's copyrights have been infringed or not. The Court has asked for Sanguine and its partners to file a reply with an advance copy to Pearson so that they can file a rejoinder. The next hearing is scheduled on 18th March, 2013.

(A copy of  the judgement can be accessed here.)
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in Copyright, Gopika, Publishing | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • IPAB on Payyannur Ring
    [*S lightly long post] Background: The Intellectual Property Appellate Board (“ IPAB ”), in its recent order in SubhashJewellery v. Payyan...
  • Satyajit Ray's sketches and copyright controversies
    A copyright row appears to have started between the Satyajit Ray Society and the Delhi Art Gallery, that is organising a countrywide exhibit...
  • Ghost Post: Samsung v. Apple Presidential Enforcement Veto
    SpicyIP subscribers recently received a short blurb from Shamnad on this FT article regarding the hypocrisy of stamping 'national inter...
  • Dorling Kindersley v. Sanguine Technical Publishers
    A recent Delhi High Court order passed on 21 January, 2013  with respect to copyright licensing has come to our notice. An analysis of the j...
  • SpicyIP Tidbit: ALCS August Distribution
    In the UK, the Authors' Licensing and Collecting Society is an organization run and owned by writers that collects money due to its mem...
  • Delhi HC rejects the "Hot News" Doctrine: A Summary
    The applicability of the Hot News doctrine was rejected recently in a landmark ruling delivered by Justice Bhat of the Delhi HC. This post i...
  • IP Research Assistant position at IIT, Madras
    Feroz Ali Khader, MHRD IP Chair at the Indian Institute of Technology (IIT) Madras, is looking for research assistants to work on various is...
  • Thalappakatti biryani trademark row
    The southern district of Dindigal in Tamil Nadu occupies a special place in the hearts of biryani lovers. In the late 1950s, one Nagasamy N...
  • SpicyIP Tidbit: GI for Pedana Kalamkari Art Form
    Image from here Recently, as The Hindu reports , Pedana Kalamkari art form received GI protection. Members of Vegetable Dye Hand Block Kalam...
  • Loss of an IP Leader: RIP Prof Daruwalla
    Most in the Indian IP firmament may have heard of the doleful demise of one of our IP leaders, Mr. Tehemtan Nasserwanji Daruwalla. He was an...

Categories

  • 126 (1)
  • 3(d) (4)
  • 3(f) (1)
  • 3(i) (1)
  • 3(k) (2)
  • Academic Writing (1)
  • access (10)
  • access to food (1)
  • access to health (3)
  • AIA (1)
  • AIDS/HIV (3)
  • Antitrust (2)
  • Bajaj v LML (1)
  • Basmati Row (2)
  • Biological Diversity (5)
  • Biologics (2)
  • biopiracy (4)
  • biotech (7)
  • Bollywood (25)
  • Broadcasters Rights (5)
  • Budget (1)
  • business method patent (2)
  • Call for papers (2)
  • Cipla (2)
  • Comparative Advertising (4)
  • Competition law (8)
  • Compulsory Licensing (27)
  • condonation of delay (1)
  • Conference (4)
  • Constitution (12)
  • Contracts (1)
  • Controller's decisions (8)
  • Copyright (112)
  • Copyright Amendment Bill 2010 (23)
  • copyright board (4)
  • Copyright Exceptions (6)
  • copyright office (1)
  • Copyright Rules (2013) (5)
  • Copyright Societies (9)
  • Counterfeiting (1)
  • creativity (1)
  • Cross Retaliation (1)
  • csir (4)
  • d (1)
  • D.U. Photocopy Case (16)
  • Darjeeling Tea (3)
  • Data Exclusivity (2)
  • Database (1)
  • DCGI (2)
  • decompilation (2)
  • defamation (9)
  • Designs (3)
  • Designs Act (3)
  • Differential Pricing (2)
  • Dilution (1)
  • Disabilities (3)
  • Disability (2)
  • DMCA (2)
  • Doha Declaration (1)
  • Domain Names (2)
  • Draft Policy of the Indian Government (2)
  • DRM (1)
  • Drug Regulation (7)
  • education (12)
  • Enercon (1)
  • Enforcement (1)
  • EU (2)
  • ex parte (2)
  • exhaustion (3)
  • Exhaustion of Rights (2)
  • Fair Dealing (8)
  • Fair Use (11)
  • Federal Circuit (1)
  • Fees (3)
  • FICCI (7)
  • FRAND (2)
  • free trade agreement (3)
  • FTA (3)
  • G.I. Registry (4)
  • gene sequences (3)
  • Generic medicine (4)
  • Geographical Indication (14)
  • Gilead (1)
  • Glenmark (5)
  • Gopika (34)
  • Guest post (11)
  • guidelines (1)
  • GWU-CII (1)
  • Herceptin (1)
  • hot news (3)
  • ICANN (1)
  • incremental innovation (1)
  • independence (1)
  • india (5)
  • Indian Government (1)
  • Indian patent litigation (27)
  • Indian Pharma (35)
  • Injunction (10)
  • Innovation (7)
  • INTA (1)
  • Intermediaries (10)
  • internet (11)
  • Internet Access Providers (IAPs) (5)
  • Internet Censorship (7)
  • IP scholarship (3)
  • IP aware (4)
  • IP Course (3)
  • IP Education (1)
  • IP Policy (11)
  • IP update (4)
  • ip writing competition (1)
  • IPAB (34)
  • ipchair (1)
  • IPO (1)
  • IPRS (5)
  • IT Act (1)
  • Journal (2)
  • judicial independence (3)
  • Jurisdiction (1)
  • Kruttika (4)
  • Legal Education (3)
  • Legal Research Tools (1)
  • Legal Scholarship (2)
  • library (2)
  • Licensing (7)
  • Madhulika (20)
  • mathematical methods (1)
  • Media law (3)
  • medical method (1)
  • Merck (4)
  • mhrd ip chair (1)
  • Microsoft (3)
  • Middle Path (1)
  • Moral Rights (2)
  • Movies (18)
  • musical work (2)
  • nanotechnology (1)
  • Natco (3)
  • natco defamation suit (5)
  • natco vs bayer (4)
  • need for transparency (1)
  • Novartis (8)
  • Novartis patent case in India (11)
  • NPEs (2)
  • nujs (1)
  • NUJS Conference (2)
  • Obituary (1)
  • obviousness (7)
  • Off-Topic (2)
  • online course (4)
  • Open Access (6)
  • Open Source (2)
  • Opposition (3)
  • Parallel Imports (4)
  • Parliament (1)
  • passing off (5)
  • Patent (52)
  • Patent act (10)
  • patent agent (5)
  • patent agent exam (9)
  • patent agent exam qualifications (3)
  • patent infringement (5)
  • Patent Licensing (2)
  • Patent litigation (2)
  • Patent Office (19)
  • patent pool (3)
  • Patent Prosecution (7)
  • Patent rules (2)
  • Patent Strategies (8)
  • Patents (9)
  • pegasus (1)
  • Personality Rights (1)
  • Pfizer (1)
  • Pharma (18)
  • Piracy (5)
  • plagiarism (3)
  • Plant Variety Protection (2)
  • post grant (1)
  • Prashant (2)
  • Preventive Detention (1)
  • Price Control (6)
  • prior publication (1)
  • Privacy (3)
  • Prizes (1)
  • public health (3)
  • Public Interest (4)
  • Publicity Rights (4)
  • Publishing (3)
  • radio (2)
  • Rajiv (18)
  • Rectification Petition (2)
  • Rejection (1)
  • research (3)
  • reverse engineering (2)
  • revocation (4)
  • rip (1)
  • Roche (2)
  • Roche vs Cipla (1)
  • Royalty (2)
  • RTI (2)
  • Scholarship (4)
  • section 16 (1)
  • Section 3(d) (7)
  • section 8 (6)
  • shamnad (11)
  • Shan Kohli (4)
  • Shouvik Kumar Guha (30)
  • Smartphones/Tablets (2)
  • Social Innovation (1)
  • Software (10)
  • software enforcement (3)
  • software patent (3)
  • Special 301 Report (1)
  • Spicy Tidbits (6)
  • spicyip (1)
  • SpicyIP Accolades (1)
  • SpicyIP Announcements (9)
  • SpicyIP Case (1)
  • SpicyIP Cases (3)
  • spicyip commiseration (1)
  • SpicyIP Events (11)
  • SpicyIP Fellowship (5)
  • SpicyIP Guest Series (22)
  • SpicyIP Interview (2)
  • SpicyIP Jobs (4)
  • SpicyIP Jobs/General (2)
  • SpicyIP Review (1)
  • SpicyIP Tidbits (11)
  • SpicyIP Weekly Review (27)
  • Statutory Licensing (1)
  • STI Policy 2013 (4)
  • Sugen (3)
  • Supreme Court of India (5)
  • Swaraj (19)
  • Tarnishment (1)
  • Technology (6)
  • Technology Transfer (5)
  • TKDL (5)
  • TPP (1)
  • trade (4)
  • Trade Secret Protection (1)
  • Trademark (59)
  • Trademark dilution (1)
  • Trademark Registry (9)
  • Traditional Knowledge (7)
  • Transparency (5)
  • treaty (1)
  • trial (1)
  • tribunals (2)
  • TRIPS (11)
  • UK (3)
  • unfair competition (5)
  • UNFCCC (1)
  • Universities Research and Innovation Bill (2)
  • US (1)
  • US Patent Reform (1)
  • US Supreme Court (3)
  • viva (3)
  • WIPO (5)
  • Working a Patent (2)
  • Workshop (4)
  • writ (1)
  • WTO (1)

Blog Archive

  • ▼  2013 (364)
    • ►  September (13)
    • ►  August (41)
    • ►  July (36)
    • ►  June (36)
    • ►  May (32)
    • ►  April (51)
    • ►  March (66)
    • ▼  February (40)
      • Off-Topic: Call for Papers from the Journal of Tel...
      • Budget 2013-14: What’s in stock for IP and innovat...
      • LDCs seek indefinite extension of transition perio...
      • Madras High Court judgment gives a boost to unauth...
      • SpicyIP Event: MIP India IP and Innovation Forum
      • National Innovation Foundation: Boosting Frugal Te...
      • SpicyIP Weekly Review (February Week 4)
      • SpicyIP Tidbit: Retraction Watch posts restored
      • Revisiting the Trans Pacific partnership agreement
      • The Sugen v. Cipla post-grant opposition: The lost...
      • Legality of trademark protection for deities in th...
      • Guest Post: The complex problem of developing mode...
      • SpicyIP Weekly Review- ( February Week 3)
      • Blocking (Counting) your Chickens before they hatc...
      • Accessibility of public libraries to persons with ...
      • The ‘Global’ Fund being criticized
      • Spicy IP Tidbit: Indian patent office puts an end ...
      • The G.I. Registry digitizes all G.I. records: Tran...
      • Dorling Kindersley v. Sanguine Technical Publishers
      • BMS Hepatitis Patent Invalidated: A Viral Effect f...
      • Patent prosecution highway: A potential game chang...
      • SpicyIP Event: Pharma IPR 2013
      • Patent Office finally takes Form 27s seriously
      • SpicyIP Weekly Review- (February Week 2)
      • Why aren’t there any takers for compulsory licenses?
      • The 19 year war- Financial Times Ltd. v Times Publ...
      • RetractionWatch fiasco: Manipulation of DMCA notic...
      • IPAB directs IPO to accept national phase patent a...
      • SpicyIP Events: MIP's 2nd Annual India IP and Inno...
      • New Unitary Patent System For Europe
      • Is there a need to break up the cartels in the rad...
      • Jailbreaking Sony Playstations To Be Illegal in In...
      • Is the suit again the Registrar of Copyright maint...
      • Déjà vu for Akhtar – nightmare before Barasat Cour...
      • Faking it! Indian Companies using IKEA’s trademarks
      • Latest In: Delhi HC bars Bisleri from using brand ...
      • Part II: Digitization- Growth trends of the Film a...
      • Part I: Digitization of content: a comparative ana...
      • Patent office notifies the next patent agent exami...
      • IPAB revokes several claims of yet another patent ...
    • ►  January (49)
  • ►  2012 (131)
    • ►  December (29)
    • ►  November (42)
    • ►  October (50)
    • ►  September (10)
Powered by Blogger.